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B cell stimulatory factor 1 (BSF-1)' is a 20,000 M,- T cell product that acts as
a costimulant with anti-Ig antibodies to cause entry of B cells into the S phase of
the cell cycle (1) . This factor, initially designated B cell growth factor (BCGF or
BCGF-I) (2) has recently been shown to act on small, resting B cells. It causes
increases in cell volume (3, 4), marked enhancement in the expression of class II
MHC molecules (5, 6), and preparation for a more prompt entry into S phase in
response to subsequent culture with anti-IgM and BSF-1 (3, 7) . Recently, BSF-1
has also been shown to induce switching in Ig class expression in LPS-stimulated
B cells, which leads to the secretion of IgGI by these cells (8-10) .
The multiple outcomes of BSF-I action on B cells and the indication that the
resting and/or early G, phase B cell is a principal target of BSF-1 activity make
important a careful examination of the requirements for BSF-1 stimulation of
resting B cells and of the stimulants to which BSF-1-prepared B cells respond . In
this study, we describe the requirements for BSF-1 action on resting B cells and
show that anti-Lyb-2 .1 mAb mimics these preparative effects . We show that BSF-
1 by itself causes some DNA synthesis by B cell blasts prepared by stimulating B
cells with anti-IgM and BSF-1 . Our results indicate that BSF-I has a principal
role as an activation factor for resting B cells, but that it may function throughout
the G, phase of the cell cycle.
Materials and Methods
Mice .
￿
Specific, pathogen-free female BALB/c, DBA/2, and (C57BL/6 X DBA/2)F,
[BDF,] mice were obtained from Charles River Breeding Laboratories, Wilmington, MA,
and were used at 8-10 wk of age .
Culture Medium.
￿
RPMI 1640 medium (Biofluids Inc., Rockville, MD) supplemented
with 10% FCS (Reheis, Kankakee, IL), penicillin (50,ug/ml), streptomycin (50 /Ag/ml), L-
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of Naval Research grant N00014-WR24108, National Science Foundation grant PCM-8217009, and
Armed Forces Radiobiology Research Institute grant 840026 . This investigation is part of a disser-
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' Abbreviations used in this paper:
￿
BSF-1, B cell stimulatory factor 1 ; PDGF, platelet-derived
growth factor; RP-HPLC, reverse-phase HPLC ; SN, supernatant ; TFA, trifluoroacetic acid .
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glutamine (2 mM), and 2-ME (0.05 mM) was used in these experiments and is referred to
as medium .
Antibodies and Mitogen.
￿
Goat anti-mouse IgM heavy chain-specific antibody, prepared
and purified as described (11), was generously provided by Drs. W. Tsang and J.
Mizuguchi, Laboratory of Immunology, NIAID. This antibody was also conjugated to
CnBr-activated Sepharose 411 (10 mg antibody per gram of Sepharose) and was used in
culture at 0.2-1 .0 ug antibody per 0.2 ml. Hybridoma supernatants containing Bet-2, a
rat anti-mouse IgM heavy chain-specific mAb, were prepared as described (12).
Monoclonal rat IgG 1 anti-BSF-1 antibody, 11 I1111 (13), was used as diluted ascitic fluid.
Ascitic fluid of a rat IgG2a anti-DNP antibody, 50C1, prepared from cells originally
obtained from Dr. Joseph Davie (Washington University School of Medicine, St. Louis,
MO), was used as a control for I IB11 (14). Purified anti-Lyb 2.1 mAb was prepared as
described by Subbarao and Mosier (15). LPS W extracted from Escherichia coli 0111 :114
was obtained from Difco Laboratories, Inc . (Detroit, MI).
Preparation ofB Cells.
￿
Enriched populations of B cells were obtained from spleen cells
from which T cells had been eliminated by the method of Leibson et al . (16). Small, dense
B cells were separated by the modified (3) Percoll gradient centrifugation procedure of
DeFranco et al. (17). Cells forming a band between 66 and 70% Percoll and having a
density of 1 .081-1 .086 g/ml were considered to be resting B cells. Cells banding between
50 and 60% Percoll were considered to be in vivo-generated blasts.
Preparation of B Cell Blasts.
￿
Small, dense B cells prepared as described above were
stimulated with anti-IgM (5 Ag/ml) plus BSF-1 (10 U/ml) for 20 h. Percoll density-gradient
centrifugation was used to isolate blasts from nonactivated cells. Blasts formed a band
between 50 and 60% Percoll .
Preparation of BSF-1.
￿
BSF-1 was partially purified from supernatants (SN) of EL-4
cells by a reverse-phase HPLC (RP-HPLC) technique, as described previously (18). Briefly,
a large batch of serum-free SN from EL-4 cells that had been induced with PMA was
adsorbed to trimethylsilylated-controlled pore glass beads (Sepralyte; Analytichem Inter-
national, Inc., Harbor City, CA). The eluted material was applied to a C18 column (A
Bondapak, Waters Associates, Milford, MA) and a gradient of acetonitrile (40-60%) in
0 .1 % trifluoroacetic acid (TFA) was used for elution. BSF-1 is generally recovered in the
45-47% acetonitrile fraction. This material is enriched ^-2,600-fold in comparison with
its activity in serum-free SN of induced EL-4 cells (18). In some experiments, we used
BSF-1 purified essentially to homogeneity. SN fluids from PMA-induced EL-4 cells were
passed over an anti-BSF-1 column, the bound material was eluted with 0.1% TFA, and
the eluate was applied to a C18 RP-HPLC column. The material obtained contained one
principal protein of 20 M, on SDS-PAGE (J . Ohara et al., manuscript in preparation). All
of the biological activities of both BSF-1 preparations are inhibited by anti-BSF-1 mAbs
(3, 10, 13); we have not observed any differences in the stimulatory activities of these
preparations. A unit of BSF-1 is defined as the concentration required to cause half-
maximal stimulation of [RHlthymidine uptake by resting B cells in the anti-IgM costimu-
lation assay (1).
Cell Culture.
￿
For the 24 h preculture, cells were incubated at 10' cells per ml per well
in 24-well Costar plates (3524; Costar, Cambridge, MA) in medium alone or in medium
to which BSF-I or anti-Lyb-2 .1 had been added. After this preincubation, cells were
washed twice in HBSS, resuspended in medium, and counted. For the secondary culture,
10' viable cells were plated per 0 .2 ml per well in flat-bottomed microtiter plates (3596 ;
Costar).
In some experiments, cells were cultured at 105 cells per well (0.2 ml) in microtiter
plates for both the preculture and the secondary culture periods. 11BI I was added to the
well at the end of the preculture period. This had the same effect as washing in the above
procedure; it eliminated BSF-1 activity in the secondary culture . Stimulants were also
added in small volumes (10 Al/well) at this time.
DNA synthesis was determined by measuring [3Hlthymidine incorporation (1 ACi per
well, 6 .7 Ci/mmol; ICN, Irvine, CA) after a 6 h labeling period. Cultures were harvested
onto glass fiber filters using a PHD automated harvester (Cambridge Technology, Inc.,TABLE I
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* Cells were washed twice after the preincubation period and cultured at 105 viable cells per 0.2 m
per well for 34 h.
$ Spleen cells from BALB/c, DBA/2, or BDF1 mice were treated with anti-Thy-1.2,anti-Lyt-1, and
anti-Lyt-2 mAbs followed by mouse anti-rat K mAb and C. Cells separated by Percoll density
gradient centrifugation andbandingbetween66 and 70% Percollwere cultured at 106cells/ml/well
for 24 h in medium or in BSF-1 (10 U/ml).
4["H]Thymidine uptake (cpm)was measured at 28-34 h of secondary culture period.
Bet-2, ratanti-mouse IgM mAb.
Cambridge, MA). Filters wee assayed for radioactivity in a model LS3801 scintillation
counter (Beckman Instruments, Inc., Fullerton, CA).
Measurement of numbers of cells in the S + G2 and M phase of the cell cycle was
carried out as previously described (17, 21, 22).
Results
BSF-1 Prepares Cells to Respond to Many Stimuli.
￿
We have previously shown
that pretreatment of small resting B cells with purified BSF-1 prepares them to
respond more promptly to anti-IgM (5 jug/ml) and BSF-1 than B cells precultured
in medium alone. We wished to determine whether preculture with BSF-1 would
prepare B cells to respond more promptly to other stimuli. Small, dense B cells
recovered from Percoll gradient separation were cultured at 106 cells per ml per
well for 24 h in medium alone or in BSF-1 (10 U/ml). After the preculture
period, cells were washed twice and counted. 105 viable cells, as determined by
trypan blue exclusion, were incubated for the secondary culture period in
microtiter wells in medium alone or in various B cell mitogens. The stimulants
used in secondary cultures were BSF-1 (10 U/ml) plus anti-IgM (5 Ag/ml), anti-
IgM (50 Kg/ml), anti-IgM coupled to Sepharose beads, and LPS (50 Ag/ml)
(Table I). Cells were labeled with [6H]thymidine for a 6 h period, beginning 28
h after initiation of the secondary culture, and they were harvested at 34 h. Cells
precultured in BSF-1 responded much more strikingly at 28-34 h to anti-IgM
plus BSF-1, to anti-IgM (50 gg/ml), and to anti-IgM beads than did cells
precultured in medium. Preculture with BSF-1 thus speeds the pace of their
subsequent response to all anti-IgM-based stimulants. Furthermore, previous
work had shown that anti-IgM (50 leg/ml) caused very meager responses at cell
densitiesof 105 per well or less. Thus, preculture with BSF-1 also allows responses
to anti-IgM at lower cell densities. BSF-1 also prepared B cells from DBA/2 and
BDFI mice to respond more promptly to LPS. However, LPS causes substantial
responses at 28-34 h in B cells pretreated with medium alone, so that the effect
Preculture conditions
Secondary culture BALB/c DBA/2 BDF1 conditions*
Medium$ BSF-1 Medium BSF-1 Medium BSF-1
Medium 670 1,031 771 1,358 1,388 2,447
BSF-1 + anti-IgM (5,ug/ml) 4,030 25,798 2,608 15,2071 4,856 29,866u
or + Bet-21
Anti-IgM (50ag/ml) 2,548 22,223 ND ND ND ND
Anti-IgM beads 4,941 22,863 17,22 57,153 13,456 66,529
LPS (50 pg/ml) 20,287 20,976 25,760 51,946 38,772 99,043520
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TABLE II
BSF-1 Preparationfor Entry into S Phase: Analysis by Measurement
of Cellular DNA
Pretreatment
(24 h)
Net percent cells in S plus G2 and M in
response to anti-IgM and BSF-1
36 h
￿
48 h
RPMI
￿
4
￿
9
BSF-1
￿
12
￿
21
Resting B cells (5 x 105/ml) were cultured for 24 h with RPMI or BSF-1
(purified by affinity chromatography and RP-HPLC; 10 U/ml). Cells were
washed and recultured for 36 or 48 h with anti-IgM (50 Wg/ml) and BSF-
1 (10 U/ml) at 5 x 105 cells/ml . Colcemid (25 ng/ml) was added at 20 h
of the second culture. Cells in S + G2 and M were determined by staining
with propidium iodide. Values recorded are (% cells in S + G2 and M) -
(% cells in S + G2 which were observed in secondary cultures in RPMI
alone [5-6%]).
of BSF-1 is mainly seen as an enhancement above these levels. In the experiment
shown in Table I and in most experiments we observed no preparation of
BALB/c B cells for response to LPS; in other experiments, we saw modest
preparation of such cells for LPS response.
To determine whether the preparative effects of BSF-1 were limited to a small
subpopulation of B cells or were a feature of a major fraction of these cells, we
measured the percentage of BSF-1-pretreated B cells that entered the S phase of
the cell cycle upon subsequent stimulation with anti-IgM (50 Yg/ml) and BSF-1.
Resting B cells (5 x 105/ml) were cultured for 24 h in BSF-1, purified by affinity
chromatography and RP-HPLC, or in medium. The cells were washed and
recultured as 5 x 105/ml in anti-IgM and BSF-1. Colcemid (25 ng/ml) was added
at 20 h of the second culture and the fraction of the cells entering S phase was
determined at 36 and 48 h. A net stimulation of 12 and 21 % of the cells to enter
S phase at 36 and 48 h, respectively, was observed in B cell precultured with
BSF-1 (Table II). As observed previously, B cells precultured with BSF-1 ap-
peared to respond ^-12 h faster to anti-IgM and BSF-I than did B cells cultured
in medium alone (3) (compare RPMI and BSF-1 preculture groups in Table I1).
These results indicate that BSF-1 acts upon a substantial fraction of resting B
cells for preparation to enter S phase.
Low Concentrations of BSF-1 Are Effective in Preparing B Cells.
￿
DBA/2 B cells
precultured with as little as 0.1 U/ml of BSF-1 exhibited enhanced responses to
LPS at concentrations from 1 to 100 ,ug/ml, to Bet-2 plus BSF-1, and to anti-
IgM beads (Fig. 1). The degree of preparation increased as preculture concen-
trations of BSF-1 were increased to 100 U/ml.
BSF-1 Must Be Presentfor an Extended Time during the Preculture Period.
￿
To
determine the duration of contact between BSF-1 and B cells necessary for
preparation to occur, we varied the times BSF-1 was present in the preculture
period. This was done in two ways. BSF-I was added to cells at the initiation of
the preculture, and 11B11, the anti-BSF-1 antibody, was added at various times
to block further BSF-1 activity. At the same times, control groups received a
control antibody, 50C1 (Fig. 2 A); I IBI I was added to control cells at the end0
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CONC. OF BSF-1 IN PRECULTURE (U/ml)
FIGURE 1 .
￿
Effect of preculture in various concentrations of BSF-1 on subsequent response
to secondary stimuli. Small, dense B cells were prepared from spleens of DBA/2 mice using
complement-mediated lysis to remove T cells and Percoll gradient centrifugation to obtain
densecells. Cells bandingbetweeni 66 and 70% Percoll were cultured for 24 h in medium or
concentrations of BSF-1 from 0.1-100 U/ml. At 24 h, after two washes, 105 viable cellsper
well were cultured for an additional 28 h in medium alone, anti-IgM beads, Bet 2 + BSF-1,
and LPS (1 wg/ml, 10 jug/ml, or 100 jug/ml). Cells were labeled with ['H]thymidine for the
last 6 h of culture.
of the preculture period. Alternatively, cells were cultured in medium, and BSF-
1 was added at various times after initiation of culture and 11 B11 was added at
the end of the 24 h preincubation (Fig. 2 B). In both of these experiments, we
took advantage of the fact that BSF-1 prepared cells to respond to anti-IgM (50
Ag/ml) and that responses to anti-IgM (50 wg/ml) can be obtained in the presence
of 11BI I (E. Rabin, J. Ohara, and W. E. Paul, manuscript in preparation).
B cells precultured in BSF-1 for 24 h responded much more promptly to anti-
IgM than did cells pretreated with medium . The addition of I IB11 at the outset
of the preculture completely inhibited preparation (Fig. 2 A). Addition of 11 B1 1
at any time thereafter led to partial inhibition . Inhibitions of 50% were obtained
by adding 11 B11 midway through the preculture period (i.e ., at -12 h) . Similarly,
delaying the addition of BSF-1 diminished the preparative effect (Fig. 2 B). 50%
diminution was observed when BSF-1 was not added until 12 h of the 24 h
preculture. Both results emphasize that BSF-1 effects require extended time for
full induction; however, partial induction can be achieved by the presence of
BSF-1 for as little as 4 h.522
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FIGURE 2.
￿
Requirement forextended exposure to BSF-1 for BSF-1-induced preparation for
response to anti-IgM (50 fag/ml). (A)Small, dense B cells(p = 1.081-1 .086 g/ml)were cultured
at 105 perwell in medium or in BSF-1 (10 U/ml). An anti-BSF-1 mAb, IIB11, was added to
thecultures either at time 0 or at increasingly later time intervals. Replicate cultures received
50C1, an anti-DNP antibody. Both were added at a final dilution of 1:5,000 of ascitic fluid.
At 24 h, all wells that had received 50C1 throughout the preculture received 11B11 to
eliminate BSF-1 activity in thesecondarycultures. (B) Othercellswere precultured in medium,
and BSF-1 or medium wasaddedto the cultures at increasing time intervals during preculture.
The final concentration of BSF-1 was 10 U/ml. At 24 h, cells received 1IBI1 (1 :5,000). (A
andB) At 24 h, medium or anti-IgM was added to cultures. Final concentration of anti-IgM
in the secondary culture was 50 Ag/ml. Cells were cultured for an additional 24 or 30 h,
labeled for 6 h with [sH]thymidine, and harvested. Control cultures of cells precultured in
medium and stimulated with anti-IgM in secondary culture, and of cells precultured in BSF-1
then cultured in medium alone are also shown. Such cultures were labeled at 30 h and
harvestedat 36 h of culture. Arrow designates points of half-maximal stimulation.
BSF-1 Does Not Mediate Its Preparative Effect by Increased B Cell Viability.
￿
We
considered the possibility that BSF-1 might mediate its function simply by
promoting B cell viability rather than by preparing the cells to respond more
promptly to subsequent stimuli. We tested this possibility by preculturing B cells
for 24 h in RPMI, BSF-1 (10 U/ml), or EL-4 SN . Numbers of viable cells at the
end of the preculture period were essentially the same in each group (Table III).
A fixed number of viable cells were then cultured with RPMI or anti-IgM (50
,ug/ml) for 28 h and the yield of viable cells was measured. The yield of viable
cells was virtually identical whether precultured in RPMI, BSF-1, or EL-4 SN
after secondary culture in anti-IgM (Table I1I). Nonetheless, B cells precultured
with either BSF-1 or EL-4 SN took up substantially more [3H]thymidine in
response to anti-IgM than B cells precultured in RPMI alone. This, together
with our previous finding that BSF-1 pretreatment markedly speeds the rate at
which cells enter S phase in response to anti-IgM (3), leads us to conclude that
the BSF-1 preparatory effect cannot be explained simply by enhanced B cell
viability.
Anti-Lyb-2.1 Mimics BSF-1 in Preparing B Cells to Respond to Secondary Stimu-
lants. Lyb-2 is an alloantigen expressed on primitive and mature cells of the B
lineage (21). Anti-Lyb-2 mAbs have been reported to stimulate B cell prolifera-
tion by themselves and to synergize with anti-IgM to heighten DNA synthesisA
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TABLE III
BSF-1 Does Not Mediate Its Effects by Increasing B Cell Viability
B
Purified splenic B cells from BALB/c mice were separated by Percoll density
gradient centrifugation.Cellsbandingbetween66 and70% Percoll andpelleting
through 70% Percoll were cultured at 106cells/ml for22 h in RPMI, BSF-1 (10
U/ml), or EL-4 SN (1:100). At the end of the preculture period, numbers of
viable cells were counted. Viable cells were then cultured at 106 cells/ml in
RPMI or anti-IgM (50 lAg/ml). The number of viable cells at 28 h of secondary
culture were determined. Cells were also cultured at 105 cells/0.2 ml/culture
well, tritiated thymidinewasadded at 28 h, and cells were harvestedat 36 h.
* 8 X 106 cells; 22 h.
$ 106 cells; 28 h.
4 105 cells/well; 28-36 h.
responses. Subbarao and Mosier (22) and Yakura et al. (23) have suggested that
anti-Lyb-2 may react with the receptor for BSF-1 . We wished to determine
whether the similar modes of action of anti-Lyb-2 and BSF-1 extended to roles
as preparatory agents, allowing a prompter entry into S phase on subsequent
stimulation.
DBA/2 B cells were used in this experiment since they possess the Lyb-2.1
alloantigen. DBA/2 B cells were precultured for 24 h with medium, BSF-1, or
anti-Lyb-2.1 . Precultured cells were washed and cultured with a series of second-
ary stimulants. Both anti-Lyb-2.1 and BSF-1 prepared DBA/2 B cells to respond
to all the stimulants tested, including LPS (Table IV). BALB/c cells, which lack
the Lyb-2.1 alloantigen, were cultured in parallel with DBA/2 cells in this
experiment, and they were notprepared by anti-Lyb-2.1 to respond to secondary
stimulants such as anti-IgM plus BSF-1 (data not shown).
The Effect ofBSF-I on Blast Cells.
￿
BSF-1 has been clearly shown to activate
resting B cells, as judged by volume increases, induction of class II MHC
molecules, and preparation to enter S phase more promptly. We now wished to
determine whether BSF-1 also caused entry into S phase of B cell blasts prepared
by stimulating resting B cells with anti-IgM (5 lag/ml) and BSF-l . Blasts isolated
by Percoll density gradient centrifugation responded very well to Bet-2 and to
goat anti-IgM. They showed meager responses to BSF-1 used at low concentra-
tions (<_10 U/ml); when BSF-1 concentrations were raised to 100 U/ml a clearer
Preculture condition
Secondary
culture ondi-
tion
Yieldof viable
cellsafter sec-
ondary culture
[6H]Thymidine
uptake§
RPMI RPM1 4.4 X 105 179
Anti-IgM 5.0 X 105 186
BSF-1 RPMI 6.2 X 105 181
Anti-IgM 5.6 X 105 4,246
EL-4 Sn RPM1 5.4 X 105 171
Anti-IgM 5.6 X 105 4,293
Preculture*
conditions
Yield of viable
cells
RPM] 5.4 X 106
BSF-1 (10 U/ml) 5.8 X 106
EL-4 SN (1 :100) 6.2 X 10652 4 B CELL STIMULATORY FACTOR 1
TABLE IV
Anti-Lyb 2.1 Prepares B Cells to Respond to Several Stimulants
[sH]thymidine uptake (cpm)*
* [3H]thymidine uptake wasmeasured at 22-28 h of thesecondaryculture period.
Spleen cells from DBA/2 mice were prepared as described for Table I and cultured
at 106 cells/ml/well for 24 h in medium, BSF-1 (10 U/ml), or anti-Lyb 2.1 antibody
(50 ag/ml).
$ Cells were washed twice after the preincubation period and cultured at 105 viable
cells per 0.2 ml perwell for 28 h.
TABLE V
Response ofB Cell Blasts Prepared with Anti-IgM and BSF-1
Resting B cells were stimulated with anti-IgM (5 ag/ml) plus BSF-1 (10
U/ml) for 20-24 h. Blasts banding between 50 and 60% Percoll were
isolated after Percoll gradient centrifugation .
* Blasts were cultured at 105 per well in Bet-2, anti-IgM (50,ug/ml), BSF-
I with or without TEPC 183, or medium with or without TEPC 183.
Bet-2 is aratanti-mouse IgM mAb; TEPC-183 is a mouse IgM myeloma
protein.
$[sH]thymidine incorporation was measured at 22-28 h of thesecondary
culture period.
response was observed, although it was considerably less than that to Bet-2 or
goat anti-IgM (Table V). Responses of B cell blasts to high concentrations of
BSF-1 were not inhibited by the IgM myeloma protein TEPC-183 (10 /cg/ml),
suggesting that residual anti-IgM from the initial stimulation of the B cells was
not required for this response.
We also prepared large B cells directly from the spleens of normal BALB/c
mice by Percoll density gradient centrifugation . These B cell blasts responded
well to LPS and to anti-IgM-beads, but failed to respond to BSF-1 (10 U/ml)
alone (Table VI).
These experiments thus indicate that BSF-1 is relatively inefficient at stimulat-
Stimulants* (uptake
Exp. I
Response
of [3H]thymidine
Exp. 2
[cpm])$
Exp. 3
Medium 26,311 4,111 2,854
Bet-2 180,950 57,763 14,451
Anti-IgM (50 Fig/ml) 204,830 141,520 93,700
BSF-1 (1 U/ml) 41,093 4,993 -
(10 U/ml) 56,937 12,966 4,338
(100 U/ml) 83,430 25,135 -
BSF-1 (1) + TEPC 183 40,184 - -
BSF-1 (10) + TEPC 183 47,722 - -
BSF-1 (100) + TEPC 183 78,066 - -
TEPC 183 (10,ug/ml) 23,180 - -
Preculture
Secondary culture conditions)
conditions$ Medium BSF-1 + anti-
IgM5 anti-IgM50 anti-Lyb-2 +
IgM5 LPS
Medium 1,435 2,413 1,948 8,807 22,877
BSF-1 2,584 13,571 20,249 40,666 64,331
anti-Lyb-2 .1 7,575 27,479 23,739 59,246 136,163RABIN ET AL,
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TABLE VI
Large B Cells Fail to Enter S Phase to BSF-1 Alone
Spleen cells from BALB/c mice were depleted of T cellsas described in
Table I. Cells banding between 50 and 60% Percoll by density gradient
centrifugation were cultured.
* Cells were cultured for 28 h at 10' per well in medium, BSF-1 (10
U/ml), LPS (50,ug/ml), or anti-IgM coupled to Sepharose beads.
$Cells were labeled with ['H]thymidine for the last 6 h of culture.
ing entry into S phase of B cell blasts prepared with anti-IgM and BSF-1, and
that it fails to stimulate large B cells found in mouse spleens.
There Is A Requirement for BSF-1 at Later Times in Responses to Anti-IgM.
Although B cell blasts are not efficiently stimulated to enter S phase when
cultured with BSF-1 alone, we did observe that isolated B cell blasts (Fig. 3 B) or
a total B cell population (Fig. 3 A) prepared by culture with BSF-1 and anti-IgM
or Bet-2 did respond better to Bet-2 plus BSF-1 than to Bet-2 alone. However,
when these responses were analyzed carefully, we found that responses to Bet-2
plus BSF-1 early in secondary culture (i.e ., 18-24 h or 22-28 h after initiation)
were only modestly diminished (20-30%) by removing BSF-1, but responses
later in secondary culture (40-46 h) were much more dependent on BSF-1; they
were diminished by 74% by removal of BSF-1.
These results are in keeping with the finding that anti-BSF-1 antibody added
at 20 h of primary culture inhibits responses to anti-IgM plus BSF-1 by only 41
when measured at 46-52 h from the initiation of culture, but by 60% when
measured at 64-70 h (Fig. 4).
The late requirement for BSF-1 in responses to Bet-2 or to low concentrations
of anti-IgM, taken together with the inefficiency of BSF-1 in causing blast cells
to divide, suggests that BSF-1 may be required in the early stages of the second
cell cycle of B cells responding to anti-IgM.
Discussion
BSF-1 is now recognized as an activation factor for resting B cells, based on its
clearly established effects on preparation for DNA synthesis, induction of MHC
class II molecules, and increases in cell volume (3-7). How BSF-1 causes these
responses is not yet understood. We can gain some insight into the mechanisms
involved in BSF-1 preparation by examining the types of responses affected by
BSF-1 preparation and also by further characterizing the requirements for the
preparation itself.
BSF-1 prepares BALB/c cells to respond to BSF-1 plus anti-IgM (5 lag/ml),
anti-IgM (50 )ug/ml), and anti-IgM beads, but only modestly, if at all, to LPS.
However, the failure to regularly prepare BALB/c B cells for LPS responses is
Stimulants*
Exp.1
['H]thymidine
Exp.2
uptake (cpm)*
Exp.3 Exp.4
Medium 3,521 5,148 4,897 18,558
BSF-1 6,199 5,761 6,111 21,234
LPS 71,150 90,824 99,847 190,373
Anti-IgM beads - 113,286 91,770 166,813526
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FIGURE 3.
￿
Late requirement for BSF-1 in the anti-IgM response. (A) Small, dense B cells
were cultured for 24 h in BSF-1 plus Bet-2. At 24 h, cells were washed twice and cultured at
105 viable cells per well in BSF-1 (10 U/ml) plus Bet-2 (1:20); Bet-2; BSF-1 plus Bet-2 plus
anti-BSF-1 mAb, I IBI1 (1 :5,000); Bet-2 plus IIB11; BSF-1; or medium alone. Cells were
labeled with ['H]thymidine beginning at 22 h, 28 h, 34 h, and 40 h, and harvested 6 h later.
Time of harvest is indicated by the midpoint of the labelling period. (B) Resting B cells were
stimulated with anti-IgM (5 wg/ml) plus BSF-1 (10 U/ml)for 20 h. Blasts bandingbetween 50
and 60% Percoll were cultured at 105 per well in BSF-1 (10 U/ml) plus Bet-2 (1 :20), Bet-2,
BSF-1, or medium. Cellswere labeled at 6-h intervals beginning at 18 h. After a 6 h labeling
period in [sH]thymidine, cells were harvested at 24 h, 30 h, and 36 h.
not general, since BSF-1 does prepare DBA/2 and BDFI B cells to respond to
LPs.
Although the mechanism through which BSF-1 prepares B cells to respond to
secondary stimulants is not clear, it does not appear to result from heightened
initial signaling through membrane IgM molecules. Anti-IgM is known to cause
rapid increases in intracellular free calcium [Ca++]i and in concentration of
inositol phosphates. Preculture of resting B cells with BSF-1 does not enhance
these increases (J . Mizuguchi et al., manuscript in preparation), despite the
heightened reactivity of the prepared B cells as measured by increased rate of
entry into S phase. Moreover, Mizuguchi et al. (manuscript submitted for
publication) have shown that BSF-1 does not, itself, lead to increased [Ca"] ;in
resting B cells.
The preparative effects of BSF-1 require extended contact between the B cells
and BSF-1 for full effect. Delaying the addition of BSF-1 for 4-8 h in a 24-hM
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FIGURE 4.
￿
Inhibitory effect of anti-BSF-1 antibody on the response to anti-IgM plus BSF-I
at laterperiodsof culture. RestingB cells were cultured at 105per well in anti-IgM (5'ag/ml)
plus BSF-I (10 U/ml). Theanti-BSF-1 mAb, 11B11, wasadded to cultures at 0, 4, 12, 14, 16,
and 20 h fora final dilution of 1:5,000 of ascites fluid. 50C1, an anti-DNP mAb, was added
to control cultures (data not shown). Cells were labeled with ['H]thymidine at 46, 52, 58, and
64 h and harvested 6 h later.
preculture period diminishes the degree of preparation; similarly, removal of
BSF-I by adding anti-BSF-1 mAb 4-8 before the end of a 24-h preculture
diminishes the subsequent response. On the other hand, the presence of BSF-I
for relatively short periods (4-8 h) does have a measurable effect. This suggests
that BSF-1 can prepare cells to varying degrees for secondary responses and that
maximal preparation requires extended contact between BSF-I and B cells. We
cannot fully exclude the possibility that individual B cells require BSF-I for only
a short time, but that only some B cells are in a BSF-I-responsive state during
any particular period of the 24-h preculture. However, the most likely hetero-
geneity of cells with regard to stimulant sensitivity would be position in the cell
cycle. Since essentially all the B cells used in these experiments are in Go or the
early portion of the G, phase, it seems very unlikely that heterogeneity in
responsiveness can explain the requirement for extended contact. Furthermore,
other well studied factors, including IL-2, epidermal growth factor, and insulin
require extended contact with their cellular targets to achieve maximal effects
(24-26). Indeed, anti-IgM itself will only cause B cells to become committed to
entry into S phase after 20-30 h of contact with B cells that have not been
prepared by prior culture with BSF-I (17) .
The capacity of BSF-I to prepare resting B cells to enter S phase in response528
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to subsequent stimuli is reminiscent of the effects of platelet-derived growth
factor (PDGF) on quiescent fibroblast lines. Thus, PDGF does not, itself, cause
growth-arrested BALB/c-3T3 cells to enter S phase but induces a state of
competence, allowing them to divide in response to epidermal growth factor or
to somatomedins (27). However, our finding that BSF-1 action on resting B cells
requires extended contact, and the fact that BSF-1 does not cause increased
[Ca"] ;in resting B cells, stand in contrast to the effects of PDGF on fibroblasts.
PDGF induces a state of competence in BALB/c-3T3 cells within 30 min (27),
and this induction is associated with an increase in [Ca"] ;(28). This suggests
that the mode ofaction of BSF-I on B cells may be quite different from that of
PDGF on fibroblasts.
Our studies add to the current consideration of the role ofLyb-2 and ofanti-
Lyb-2.1 antibody in the stimulation of B cells. Both Yakura et al. (23) and
Subbarao and Mosier (15) have reported that monoclonal anti-Lyb-2 .1 stimulates
DNA synthesis by resting B cells. Indeed, F(ab) fragments of anti-Lyb-2 .1 have
been reported to be stimulatory (15). Low concentrations of anti-Lyb-2.1 co-
stimulate with anti-IgM, but not with crude preparations containing BSF-1 . This
has led to the suggestion that anti-Lyb-2 .1 mimics BSF-1 activity . Yakura et al.
have also observed that anti-Lyb-2 .1 blocks absorption of BSF-1 by DBA/2 B
cells; they have therefore proposed that Lyb-2 is the cellular receptor for BSF-1
(23). Our data indicate that anti-Lyb-2.1 mimics BSF-1 in that it prepares cells
to respond more promptly to several stimulants, including anti-IgM plus BSF-1,
anti-IgM (50 kg/ml), LPS, and anti-Lyb-2 .1 plus anti-IgM. However, the finding
that anti-Lyb-2.1 can stimulate B cell entry into S phase without costimulants,
while BSF-I alone fails to do so, calls for caution in concluding that anti-Lyb-2.1
is directed to the BSF-1 receptor. Progress in purifying BSF-I should make
possible the development of binding assays that will allow a more direct assess-
ment of the nature of the BSF-I receptor and its relationship to Lyb-2.
BSF-1 was initially described as a costimulant with anti-IgM antibodies of B
cell entry into S phase. It was anticipated that BSF-I acted on B cells in a manner
analagous to the action of IL-2 on T cells (29). That is, it was expected that
resting B cells would be unresponsive to BSF-1 and that activation with anti-IgM
would induce a state of BSF-I sensitivity. Addition of BSF-1 would then deter-
mine that the activated B cell would enter S phase. Our data and those ofothers
have clearly shown that BSF-1 can act on resting B cells. Thus, at least part of
the initial postulate ofthe mode of BSF-I action must be rejected. To determine
whether B cell blasts could be stimulated by BSF-1 to enter S phase, we prepared
blasts by culture with BSF-I and anti-IgM. These cells incorporated modest
amounts of [sH]thymidine when stimulated with relatively high concentrations
of BSF-1; large B cells harvested directly from the spleens of mice failed to
synthesize DNA when stimulated with BSF-1 . This leads us to conclude that in
the first round of cell division of B cells stimulated with BSF-1 and anti-IgM,
BSF-1 exerts its major role as an activation factor, working on Go and early G,
B cells. It appears to have only a minor role on late G, B cells; considering the
high concentrations of BSF-1 required, the late G, effect may be of limited
physiologic significance.
The observation that anti-BSF-1 mAb, added as late as 20 h of culture, hasinhibitory effectson responses to anti-IgM plus BSF-1 could nevertheless indicate
an important requirement for BSF-1 late in the initial cell cycle. An alternative,
and we believe more plausible, possibility is that this inhibition reflects a require-
ment for BSF-1 in the early G, phase of the second round of cell division
stimulated by anti-IgM. This is supported by the finding that the requirement
for BSF-1 is considerably more striking when [3H]thymidine uptake is evaluated
at 60-70 h of culture than at 46-52 h. Direct examination of the requirement
ofBSF-1 for the second round of cell division is now in progress.
Indeed, it is quite possible that the recently described IgGI-inducing activity
of BSF-1 is due to its function on early G, cells in the first and subsequent cell
cycles. Thus, it has been shown that B cells stimulated with LPS will secrete little
or no IgG, unless BSF-1 is added to the culture. Moreover, the cells that are the
antecedents of the IgGI-secreting cells lack membrane IgG, at the outset of the
culture, indicating that Ig heavy chain switching occurs in response to the action
ofBSF-1 (30). We suggest that the action ofBSF-1 in early G, phase may initiate,
in properly stimulated cells, the induction of the intracellular signals required
for switching. Whether the switching that occurs under the influence of BSF-1
is limited to the y, H chain will await analysis of expression of other Ig classes
and ofcostimulants other than LPS. Recent studies (31) indicate that BSF-1 also
promotes the expression of IgE.
Summary
BSF-1 prepares resting BALB/c, DBA/2, and BDF, B cells to enter S phase
more promptlyin response to subsequent culture withanti-IgM-based stimulants.
It prepares DBA/2 and BDF, B cells to respond to LPS, but its preparative effect
for LPS responses ofBALB/c B cells is both inconstant and meager. Preparation
mediated by BSF-I requires extended contact of B cells with the stimulant for
full effect. Half-maximal preparation requires ^-12 h of contact, as judged by
delayed addition ofBSF-1 or by inhibition ofBSF-1 action with anti-BSF-1 mAbs.
BSF-1 preparative action on resting DBA/2 B cells is mimicked by anti-Lyb-2.1
antibody. B cell blasts prepared by culture with BSF-1 and anti-IgM show modest
responses to high concentrations of BSF-1; large B cells directly isolated from
the spleen are not stimulated to enter S phase by BSF-1 . These results lead us to
conclude that BSF-1 functions principally as an activation factor for resting B
cells.
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